p38 MAP kinase inhibitor
Overexpression of endophilin A1 exacerbates synaptic alterations in a mouse model of Alzheimer’s disease
... of p38 MAP ...of p38 MAP kinase increased complex IV activity and ATP levels, demonstrating a link between EP-induced ROS to p38 MAP kinase ...EP/ROS/p38 ...
14
MOLECULAR MODELING AND DRUG DISCOVERY OF POTENTIAL INHIBITORS FOR ANTICANCER TARGET GENE MELK (MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE)
... zipper kinase (MELK), a member of the AMP serine/threonine kinase family, exhibits multiple features consistent with the potential utility of this gene as an anticancer ...protein kinase, and that ...
5
Gene Expression Profiling of Human c Kit Mutant D816V
... system for the regulated expression of wild-type c-Kit and mutant D816V-c-Kit in huSCF/c-Kit null U937 cells and assessed the cells’ mitogenic potential. We performed micro- array profiling of huSCF activated wild-type ...
16
Drug evaluation: VX 702, a MAP kinase inhibitor for rheumatoid arthritis and acute coronary syndrome
... of p38 MAPK is associated with the over- production of proinflammatory mediators, including TNFα, IL-1β, COX-2, IL-6, IL-12 and ...of p38 MAPK activity by VX-702 has the potential for the treatment of ...
6
From mouth to macrophage: mechanisms of innate immune subversion by Mycobacterium avium subsp. paratuberculosis
... signal-regulating kinase 1; AP-1-Jun: Activator protein-1-JUN; ATP: Adenosine triphosphate; BCG: Bacillus Calmette-Guerin; Bcl-2: B-cell lymphoma 2; CARD15: Caspase associated recruitment domain 15; CD4+: Cluster ...
15
p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL 8 production, and enteritis
... specific p38 inhibitor SB203580-hydrochloride (100 µg in water), or with SB202474, an inactive ana- logue (100 µg in 5 mM Hcl) (Calbiochem-Nov- abiochem ...
11
Non-Classical P38 Map Kinase Functions: Cell Cycle Checkpoints and Survival
... activates p38 MAPK, but pharmacological and genetic inhibition of this path- way enhances the apoptotic effect of etoposide ...II inhibitor) and cisplatin (DNA crosslinker) activate p38 MAPK and ...
9
Mechanisms of tumor necrosis factor-α-induced interleukin-6 synthesis in glioma cells
... JAK inhibitor I and apocynin were obtained from Calbiochem-Novabiochem ...phospho-specific p38 MAP kinase, p38 MAP kinase, phospho-specific SAPK/ JNK, SAPK/JNK, ...
8
P38 MAP kinase inhibitors as potential therapeutics for the treatment of joint degeneration and pain associated with osteoarthritis
... presence or absence of various concentrations of inhibitor (8, 40, 125, 200, 500, 1000 or 2000 nM in RPMI-1640 with 2 mM glutamine, 10 mM HEPES, 1 mM sodium pyruvate, 10% fetal calf serum, and 0.05 mM 2-β-mercap- ...
8
Molecular Docking of Triazine analogues
... transduction. MAP kinase causes several diseases, such as asthma osteoarthritis, rheumatoid arthritis, and chronic inflammatory autoimmune ...are inhibitor of p38 MAP kinase. ...
6
Strong inhibition of TNF α production and inhibition of IL 8 and COX 2 mRNA expression in monocyte derived macrophages by RWJ 67657, a p38 mitogen activated protein kinase (MAPK) inhibitor
... to p38 MAPK, phospho-p38 MAPK, and phospho-MAP- KAPK-2 were purchased from Cell Signalling Technologies (Beverly, MA, USA) and detecting antibody peroxidase- swine-anti-rabbit was from DAKO ...
9
Differential regulation of anti-inflammatory genes by p38 MAP kinase and MAP kinase kinase 6
... The p38 pathway regulates the resolution of inflammatory responses by increasing expression of anti-inflammatory cytokines to promote wound healing and ...Blocking p38 inhibits the expression of IL-10 and ...
5
Role of the stress activated protein kinases in endothelin induced cardiomyocyte hypertrophy
... stress-response MAP kinase, p38, by over- expression of activated mutants of various components of the pathways is sufficient to induce a hypertrophic response in cardiomyocytes, but it is not clear ...
11
CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation
... prosurvival kinase Akt, and the baseline insulin-perfused hearts showed the highest de- gree of Akt phosphorylation (Figures 6A through ...an inhibitor of the Akt target mTOR, did not alter the ability of ...
9
The Ca2+ activated SK3 channel is expressed in microglia in the rat striatum and contributes to microglia-mediated neurotoxicity in vitro
... apamin and ~83% by 5 nM tamapin, but was not affected by 250 pM tamapin (Figure 3A). Once induced, iNOS is enzymatically active and produces nitric oxide (NO). NO production was increased ~3 fold; i.e., from 19 ± 5 ...
15
Gerwig, Tobias (2002): Prevention of Ischemia-Reperfusion Injury in the Rat Liver by Atrial Natriuretic Peptide: Insights into Mechanisms and Mode of Cell Death. Dissertation, LMU München: Fakultät für Chemie und Pharmazie
... The activation of PKA has been shown to be antiapoptotic in numerous studies. For example, PKA expression is increased in a wide range of cancers (Alper et al., 1999) and antisense RNA of PKA produces a marked decrease ...
122
Targeting of TGF-β-activated protein kinase 1 inhibits chemokine (C-C motif) receptor 7 expression, tumor growth and metastasis in breast cancer
... of kinase activity was caused by upstream signaling ...TAK1 inhibitor 5Z-O dose-dependently inhibited TAK1 activity without affecting the expression of TAK1 protein (Figure ...
13
LPS Induced Proliferation and Chemokine Secretion from BEAS 2B Cells
... 1/2, p38 and JNK MAPK, and, on the other hand lead to increased cell proliferation and secretion of ...1/2, p38 and JNK MAPK, tyro- sine kinases, PI3-kinase, IRAK, and NFκB to increased IL-8 ...
12
P38 MAP Kinase inhibition promotes primary tumour growth via VEGF independent mechanism
... cer[7,8]. P38-MAPK activation has been demonstrated in many human cancers but the findings have not been con- ...NFκB, p38 and JNK activation in colonic ...of p38-MAPK acti- vation in gastric ...
6
The Aurora kinase A inhibitor TC-A2317 disrupts mitotic progression and inhibits cancer cell proliferation
... Aurora kinase A may be useful as a cancer ...Aurora kinase A inhibitors, including ENMD- 2076, MK-5108 (VX-689), MLN-8054, and MLN-8237 (alisertib), are undergoing clinical trials [8, 16, ...Aurora ...
18